Overview

Efficacy of Thymosin alpha1 for Severe Sepsis

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of thymosin alpha 1 for treating severe sepsis.
Phase:
N/A
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Thymalfasin